HIF1A and cancer: Aberrant signaling through PI3K/AKT pathway, the activation status of two opposing metabolic sensors such as mTOR and AMPK, the transcriptional activity of HIF-1, MYC and p53 are all considered the main regulators of glucose metabolism in cancer cells [3,4].